Latest Breaking News On - Oncimmune immuno - Page 6 : comparemela.com
Oncimmune new ImmunoINSIGHTS contract further validates offering and supports expected sales growth
directorstalkinterviews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from directorstalkinterviews.com Daily Mail and Mail on Sunday newspapers.
Investegate |Oncimmune Hldngs PLC Announcements | Oncimmune Hldngs PLC: Agreement signed with major cancer center
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
Oncimmune Holdings PLC (AIM:ONC) | RNS | Oncimmune Hldngs PLC - Agreement signed with major cancer center
proactiveinvestors.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.co.uk Daily Mail and Mail on Sunday newspapers.
Our intimate understanding of the human immune system enables us to harness its sophisticated response to disease to detect cancer earlier and to support the development of better therapies. The key to improving cancer survival is early detection and better selection for therapy. As a company, we are driven by our passion to improve cancer survival and to give people extra time. Oncimmune is a leading immunodiagnostics developer, primarily focused on the growing fields of immuno-oncology, autoimmune disease and infectious diseases. Oncimmune has a diversified and growing revenue from its portfolio of diagnostic products to detect early-stage cancer and a
UK TRADING UPDATE SUMMARY: Triple Point Social Ups Credit Facility
Tue, 15th Dec 2020 22:00
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
Triple Point Social Housing REIT PLC - London-based real estate investment trust - Increases existing revolving credit facility jointly provided by Lloyds Bank PLC and NatWest Bank PLC. The RCF will increase to GBP160 million from GBP130 million. Has also simultaneously extended the RCF s initially agreed four-year term by a year to December 2023. The term of the RCF may be extended by a further year, to December 2024.